Biomerica Inc Asset Resilience Ratio

Latest as of August 2021: 1.44%

Biomerica Inc asset resilience ratio. Biomerica Inc (BMRA) has an Asset Resilience Ratio of 1.44% as of August 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Biomerica Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$165.32K
Cash + Short-term Investments

Total Assets

$11.52 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Biomerica Inc (1999–2018)

Asset resilience ratio of Biomerica Inc from 1999 to 2018. This chart shows how Biomerica Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Biomerica Inc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Biomerica Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Biomerica Inc total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $165.32K 1.44%
Total Liquid Assets $165.32K 1.44%

Asset Resilience Insights

  • Limited Liquidity: Biomerica Inc maintains only 1.44% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Biomerica Inc Industry Peers by Asset Resilience Ratio

Compare Biomerica Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
BMC Medical Co. Ltd. A
SHE:301367
Medical Devices 44.96%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Biomerica Inc Asset Resilience Ratio by Year (1999–2018)

Biomerica Inc asset resilience ratio by year from 1999 to 2018. The table below shows the annual Asset Resilience Ratio data for Biomerica Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2018-05-31 0.00% $0.00 $5.22 Million --
2017-05-31 0.00% $0.00 $5.02 Million --
2016-05-31 0.00% $0.00 $5.73 Million --
2015-05-31 0.00% $0.00 $6.12 Million --
2014-05-31 0.00% $0.00 $6.47 Million --
2013-05-31 0.00% $0.00 $6.39 Million --
2012-05-31 0.00% $0.00 $5.57 Million --
2009-05-31 1.94% $100.00K $5.15 Million +1.93pp
2008-05-31 0.01% $355.00 $5.11 Million -0.01pp
2007-05-31 0.02% $532.00 $3.22 Million -0.12pp
2006-05-31 0.14% $3.28K $2.43 Million -0.01pp
2005-05-31 0.14% $8.18K $5.79 Million -0.33pp
2004-05-31 0.47% $26.12K $5.57 Million +0.23pp
2003-05-31 0.24% $13.11K $5.55 Million +0.19pp
2002-05-31 0.05% $2.53K $5.28 Million -0.73pp
2001-05-31 0.78% $41.57K $5.35 Million -0.69pp
2000-05-31 1.47% $98.77K $6.74 Million +0.18pp
1999-05-31 1.28% $100.00K $7.80 Million --
pp = percentage points

About Biomerica Inc

NASDAQ:BMRA USA Medical Devices
Market Cap
$7.80 Million
Market Cap Rank
#27537 Global
#5705 in USA
Share Price
$1.70
Change (1 day)
-1.73%
52-Week Range
$1.49 - $2.88
All Time High
$16.00
About

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more